1 / 6

AI-Enabled Drug Discovery And Clinical Trials Market Growth

The global AI-enabled drug discovery and clinical trials market will grow at 24.65% CAGR during 2021-2027 owing to the increased research development in Artificial Intelligence (AI), and includes technologies like machine learning, deep learning, recursive learning. Moreover, Artificial Intelligence (AI) can enhance various processes like data collection and analysis, generation of a virtual 3D model that depicts drug and binding interaction, design clinical studies, optimize clinical trials, and provide real-world evidence analysis.

Research1
Download Presentation

AI-Enabled Drug Discovery And Clinical Trials Market Growth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AI-Enabled Drug Discovery And Clinical Trials Market

  2. About VynZ Research… • VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. We have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies. • VynZ Research has one of the most qualified & experienced analysts, who are constantly tracking the markets and the technologies. The research team has years of proven experience and wide knowledge & understanding of the technology, application, business models, and regulators of the segments and the value chain involved. • A trusted & proven methodology that involves highest quality of primary research, secondary analysis collated & verified through various sources including cross checking with different industry experts. • Serving wide range of customers most of them from Fortune 2000 companies • With a dedicated 24x7 customer helpline our customers can reach for specifying their needs • Developing long term relationship with the clients and satisfying them is one of the crucial notches of the company. VynZ Research aims at gaining and retaining its clients in order to make long term customer relationship.

  3. AI-Enabled Drug Discovery And Clinical Trials Market The global AI-enabled drug discovery and clinical trials market will grow at 24.65% CAGR during 2021-2027 owing to the increased research development in Artificial Intelligence (AI), and includes technologies like machine learning, deep learning, recursive learning. Moreover, Artificial Intelligence (AI) can enhance various processes like data collection and analysis, generation of a virtual 3D model that depicts drug and binding interaction, design clinical studies, optimize clinical trials, and provide real-world evidence analysis. Furthermore, the increased number of synergistic activities, increased demand to reduce the cost of new drug discovery and their production, and increased adoption of cloud-based services and applications will propel the growth of the market. Nevertheless, the acceptance of artificial intelligence is substantially growing, as quicker, efficient, and cost-effective drug discovery and is gaining traction among the pharmaceutical industry stakeholders.

  4. AI-Enabled Drug Discovery And Clinical Trials Market The COVID-19 outbreak has forced the pharma and biotech companies to adopt Artificial Intelligence so as to improve accuracy and speediness in drug discovery. Thus, providing a platform to have huge investment towards fast growth and trials of drugs. Based on end-user, academic & research centers and contract research organizations will have a significant contribution to the market as there is a need to improve the quality of care and streamline the workflow of the facilities. Moreover, the increased demand to maintain facility workflow and rearrange the work to enhance the quality of care will augment the growth of the AI-enabled drug discovery and clinical trials market. North America dominates the global AI-enabled drug discovery and clinical trial market owing to the increasing number of clinical trials, increased spending on biopharmaceutical R&D, and increased optimistic perception towards AI in businesses. In addition, the presence of major industry players and increased awareness about the integration of AI in the drug discovery process play a pivotal role in propelling the growth of the AI-enabled drug discovery and clinical trials market in the region.

  5. AI-Enabled Drug Discovery And Clinical Trials Market In September 2021, Accutar Biotechnology, Inc. has announced that the U.S. Food and Drug Administration (FDA) has cleared the company’s investigational new drug application (IND) for phase 1 Trial of AC0682 for the treatment of patients with estrogen receptor (ER)-positive breast cancers. The prominent players in the AI-enabled drug discovery and clinical trials industry include Accutar Biotechnology Inc., AiCure, Ardigen, Atomwiseinc., BERG LLC, Biovista, Cloud Pharmaceuticals, Inc., Cyclica Inc., Symphony Innovation, LLC, and Benevolent AI.

  6. For Sample Report :- https://www.vynzresearch.com/healthcare/ai-enabled-drug-discovery-and-clinical-trials-market/request-sample www.vynzresearch.com

More Related